Adam T. Stearns

Adam T. Stearns

Auto-generated profile, based on publicly available information

Adam T. Stearns

Sir Thomas Browne Academic Colorectal Unit Norfolk and Norwich University Hospital Trust Norwich UK

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2007 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Closed access
STSimon J. Thomas
Simon J. Thomas
CMClaire McDougall
Claire McDougall
IBIain D.M. Brown
Iain D.M. Brown
MJMarie-Claire Jaberoo
Marie-Claire Jaberoo
ASAdam Stearns
Adam Stearns
IKIan G. Kelly
Ian G. Kelly

1 May 2010 in Annals of Surgery
Verified
Journal Article
Closed access
ASAdam T. Bmbch Stearns
Adam T. Bmbch Stearns
ABAnita Bmbs Balakrishnan
Anita Bmbs Balakrishnan
DRDavid B. Rhoads
David B. Rhoads
ATAli Mbbs Tavakkolizadeh
Ali Mbbs Tavakkolizadeh
Objective: We set out to examine the short-term regulation of the intestinal sodium/glucose cotransporter SGLT1 by its substrate glucose and sweet taste analogs. Summary Background Data: Intestinal SGLT1 is a putative target for antidiabetic therapy; however, its physiological regulation is incompletely understood, limiting its application as a pharmacological target. While it is clearly regulated by dietary composition over a period of days, its short-term regulation by nutrients is unknown. Methods: Sprague-Dawley rats were anesthetized, and the duodenum cannulated. d-glucose, d-fructose, saccharin, d-mannitol, and water were infused for 3 hours, before harvest of proximal jejunum for SGLT1 analysis with Western blotting and quantitative polymerase chain reaction. In further experiments, the receptor region was identified by d-glucose infusion of isolated regions. Lastly, the vagus was de-afferented with capsaicin, and 5HT3-receptor activation of vagal afferents inhibited using ondansetron, before repeating experiments using water or d-glucose infusion. Results: Infusion of d-glucose led to 2.9-fold up-regulation in SGLT1 compared with water or iso-osmotic d-mannitol; this effect was replicated by d-fructose or saccharin. This response was strongest following isolated infusions of duodenum and proximal jejunum, with a blunted effect distally; topography matched the expression profile of sweet taste receptor T1R2/T1R3. The reflex was abolished by capsaicin pretreatment, and blunted by ondansetron. Conclusions: The agonist response implicates the luminal-based sweet-taste receptor T1R2/T1R3, with the reflex apparently involving vagal afferents. The proximal nature of the sensor coincides with the excluded biliopancreatic limb in Roux-en-Y gastric bypass, and this may provide a novel explanation for the antidiabetic effect of this procedure.

1 November 2009 in American Journal of Physiology-Gastrointestinal and Liver Physiology
Verified
Journal Article
Closed access
PDF file
ASAdam T. Stearns
Adam T. Stearns
ABAnita Balakrishnan
Anita Balakrishnan
ATAli Tavakkolizadeh
Ali Tavakkolizadeh
Roux-en-Y gastric bypass (RYGB) has become the gold-standard bariatric procedure, partly because of the rapid resolution of accompanying diabetes. There is increasing evidence this is mediated by duodenal exclusion. We hypothesize that duodenal exclusion suppresses intestinal Na+/glucose cotransporter SGLT1-mediated glucose transport, improving glucose handling, and aimed to test this in a rodent RYGB model. Sprague-Dawley rats underwent sham procedure or duodenal exclusion by RYGB (10 cm Roux, 16 cm biliopancreatic limbs). Animals were maintained for 3 wk on a Western diet, before harvest at 10 AM, 4 PM, and 10 PM. Sections were taken from each limb for hematoxylin and eosin staining, and morphological assessment was performed. Functional glucose uptake studies, along with Western blotting and quantitative PCR, were performed on Roux limb. Histology showed morphometric changes in Roux and common limbs, with increase in villus height and crypt depth compared with BP and sham jejunum. Despite this, glucose transport was reduced by up to 68% ( P < 0.001) in the Roux limb compared with sham jejunum. Normal diurnal rhythms in glucose uptake were ablated. This occurred at a posttranscriptional level, with little change in message but appearance of different weight species of Sglt1 on Western blotting. We have shown duodenal exclusion significantly influences both intestinal structure and glucose transport function, with glucose absorptive capacity reduced after RYGB. This provides a novel mechanistic explanation for some of the antidiabetic effects of RYGB.

28 September 2019 in Colorectal Disease
Verified
Journal Article
Closed access
PDF file
AFAlexandra Fielding
Alexandra Fielding
RWRebecca Woods
Rebecca Woods
SMSyed R. Moosvi
Syed R. Moosvi
RWRichard Q. Wharton
Richard Q. Wharton
CSChristopher T.M. Speakman
Christopher T.M. Speakman
ASAdam T. Stearns
Adam T. Stearns

2 May 2021 in Colorectal Disease
Verified
Journal Article
Closed access
PDF file
JCJasmine Crane
Jasmine Crane
MHMazin Hamed
Mazin Hamed
JBJoseph P. Borucki
Joseph P. Borucki
AEAhmed El‐Hadi
Ahmed El‐Hadi
ISIrshad Shaikh
Irshad Shaikh
ASAdam T Stearns
Adam T Stearns

1 October 2007 in Journal of Chromatography B
Verified
Journal Article
Closed access
TZT. Zhang
T. Zhang
DWD.G. Watson
D.G. Watson
CAC. Azike
C. Azike
JTJ.N.A. Tettey
J.N.A. Tettey
ASA.T. Stearns
A.T. Stearns
CPC.J. Payne
C.J. Payne